January 2019, Vol 173, No. 1, Pages 3-112

This double-blind, randomized clinical noninferiority trial evaluates whether placebo treatment is significantly inferior to 3 days of oral amoxicillin treatment in HIV-uninfected children aged 2 to 59 months with nonsevere fast-breathing pneumonia in a malaria-endemic region of Malawi, Africa.

This population-based sibling-matched study assesses the association between surgical procedures that require anesthesia in children aged 5 to 6 years and child development in Ontario, Canada.

This study examines self-reported data from the 2013 and 2016 Behavioral Risk Factor Surveillance System in Washington State to quantify the association between presence of an adult reporting alcohol misuse and children’s living in a home with an unsafely stored firearm.

This study evaluates the association of nurse shift-level workloads in the neonatal intensive care unit with missed nursing care using nurse-reported data.

This cohort study compares the use of fetal magnetic resonance imaging and ultrasonography in the identification of brain abnormalities associated with Zika virus.

This study characterizes the duration of clinical trials submitted to the US Food and Drug Administration for pediatric drug approvals, with a focus on drugs used for long-term therapy.

This cohort study evaluates the characteristics, completion rate, and transparency of study design and results for mandatory pediatric postmarketing studies required under the Pediatric Research Equity Act.

This systematic review and meta-analysis examines the safety and efficacy of bacillus Calmette-Guérin vaccination at birth or later points in infants who are preterm and/or had low birth weights compared with ones who are full term and/or had normal birth weights.

This large population-based Canadian cohort study evaluates the association between prenatal exposures to airborne pollutants and autism spectrum disorder.

This study investigates the utility of reinterpreting the genomic test results of pediatric patients who previously underwent genomic epilepsy testing.

This multicenter cohort study describes the natural progression of symptom change by age group (5-7, 8-12, and 13-18 years) and sex and develops centile curves to inform families about children after concussion recovery.